Recommendations of the Public Health Service Advisory Committee on Immunization Practices, Center for Disease Control, U.S. Department of Health, Education, and Welfare, Atlanta, Georgia: Influenza vaccine. Ann. Intern. Med., 87, 316, 1977.
2.
Amantadine: does it have a role in the prevention and treatment of influenza? NIH Consensus Development Conference Summary.Ann. Intern. Med., 92, 256, 1980.
3.
ShethK.J., FreemanM.E., EisenbergC., SedmakG.V.: Influenza virus immunization: Antibody response and adverse effects in children with renal disease.JAMA, 239, 2559, 1978.
4.
PabicoR.C., DouglasR.G., BettsR.F., McKennaB.A., FreemanR.B.: Influenza vaccination of patients with glomerular diseases.Ann. Intern. Med.81, 171, 1974.
5.
WilliamsG.W., SteinbergA.D., ReinertsenJ.L., KlassenL.W., DeckerJ.L., DolinR.: Influenza immunization in systemic lupus erythematosus: A double-blind trial.Ann. Intern. Med., 88, 729, 1978.
PabicoR.C., DouglasR.G., BettsR.F., McKennaB.A., FreemanR.B.: Antibody response to influenza vaccination in renal transplant recipients: Correlation with allograft function.Ann. Intern. Med., 85, 431, 1976.
15.
StiverH.G., GravesP., MeiklejohnG., SchroterG., EickhoffT.C.: Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients.Infect. Immun.16, 738, 1977.
OrtbalsD.W., MarksE.S., LiebhaberH.: Influenza immunization in patients with chronic renal disease.JAMA, 239, 2562, 1978.
19.
OsanlooE.O., BerlinB.S., PopliS., IngT.S., CummingsJ.E., GandhiV.C., GeisW.P., HanoJ.E.: Antibody responses to influenza vaccination in patients with chronic renal failure.Kidney Int., 14, 614, 1978.
20.
BriggsW.A., RozekR.J., ShillisJ.L., MahajanS.K., BrackettR.G., BrandonF.B., McDonaldF.D.: Cellular and humoral immune responses of hemodialysis patients to bivalent influenza vaccination.ASAIO Journal, 3, 20, 1980.
21.
PhairJ., KauffmanC.A., BjornsonA., AdamsL., LinnemannC.Jr.: Failure to respond to influenza vaccine in the aged: Correlation with B-cell number and function.J. Lab. Clin. Med., 92, 822, 1978.
22.
ParkesD.: Amantadine.Adv. Drug Res., 8, 11, 1974.
23.
IngT.S., DaugirdasJ.T., SoungL.S., KlawansH.L., MahurkarS.D., HayashiJ.A., GeisW.P., HanoJ.E.: Toxic effects of amantadine in patients with renal failure.Can. Med. Assoc. J., 120, 695, 1979.
24.
BleidnerW.E., HarmonJ.B., HewesW.E., LynesT.E., HermannE.C.: Absorption, distribution and excretion of amantadine hydrochloride.J. Pharmacol. Exp. Ther., 150, 484, 1965.
25.
IngT.S., DaugirdasJ.T., SoungL.S.: The posology of amantadine: A note of caution.JAMA, 243, 1844, 1980.
HoradamV.W., SharpJ.G., SmilackJ.D., McAnalleyB.H., GarriottJ.C., StephensM.K., PratiR.C., BraterD.C.: Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.Ann. Intern. Med., 94, 454, 1981.
28.
WuM.J., IngT.S., SoungL.S., DaugirdasJ.T., HanoJ.E., GandhiV.C.: Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.Clin. Nephrol., in press.